Results: The proportion of AQ scores >32 (indicative of autism diagnosis) was 6.6% for PD, 1.1% for GR and 1.2% for TC. For AQ scores >26 (indicative of high autism traits) respective percentages were: 21.4%, 2.8% and 2.4%. Mean group differences for autism traits (PD > GR > TC) and social functioning (PD < GR < TC) were all significant, albeit with small effect sizes for GR vs TC. Within the PD and GR group, autistic traits showed a negative impact on overall social functioning above and beyond the effect of positive psychotic symptoms. Discussion: At least 1 in 5 individuals with a psychotic disorder is characterized by elevated levels of autism traits. In addition, levels of social functioning are negatively affected by autisms traits in individuals with (a genetic predisposition to) psychotic disorders. These findings warrant specific clinical guidelines for psychotic patients who present themselves with autistic comorbidity. Background: Motivation deficits have been linked to poor functional outcomes in schizophrenia (SZ) and major depressive disorder (MDD) and represent an unmet therapeutic need. Recent conceptualizations of the motivation system have outlined five inter-related reward processes, whereby (1) reward responsiveness (i.e. "liking") and (2) reward prediction (i.e. "wanting", established through appropriate reward learning) converge to inform both (3) reward valuation and (4) effort valuation which is associated with a cost-benefit analysis, followed by (5) the development and execution of an action plan to achieve the desired outcome. The inclusion of approach motivation within the RDoC Positive Valence System further underscores its importance as a pervasive symptom that cuts across traditional diagnostic boundaries. Previous investigations, however, have typically only focused on isolated reward processes, often within single diagnostic groups. Thus, in line with emerging dimensional approaches to examining psychopathology, the present study sought to utilize a cluster-analytic approach to objectively evaluate the multiple facets of the motivation system concurrently across SZ, MDD, and healthy control (HC) participants. Methods: The study sample consisted of 39 SZ, 38 MDD, and 39 HC participants. Participants were administered a series of assessments to evaluate symptom severity and cognitive functioning. Discrete facets of the motivation system were measured using an extensive battery of objective computerized tasks. Variables of interest were extracted from each task and entered into a principal components analysis in order to explore the factor structure of the motivation framework. Factor scores were subsequently applied to K-means cluster analysis to identify subgroups of individuals with similar motivation profiles. Results: Principal components analysis revealed five distinct motivation factors: hedonic capacity, reward expectancy and learning, cost-benefit decisionmaking, goal-directed decision-making, and effort expenditure. K-means clustering identified two distinct subgroups of individuals based on their motivation task performance. The first cluster demonstrated impaired hedonic capacity (t(114)=-3.7, p<.001), whereas the second cluster was characterized by impairments in cost-benefit decision-making (t(114)=5.9, p<.001), goal-directed decision-making (t(114)=7.3, p<.001), and effort expenditure (t(114)=6.3, p<.001). Although clusters did not differ in symptom severity, the second cluster was associated with significantly greater cognitive impairments (t(114)=6.4, p<.001). Importantly, all diagnostic groups were well represented in each cluster, though with significantly different distributions. Discussion: Our dimensional investigation revealed a multi-faceted motivation framework comprised of five distinct components. The emergence of two unique motivation performance profiles highlights the extensive heterogeneity of clinical amotivation and its dimensionality across disorders. Further, the pattern of motivation impairments within these profiles raises the possibility of distinct underlying neural substrates, with implications for specific therapeutic targets. Background: Evidence suggests that positive psychotic symptoms are more prevalent in early adulthood. However, studies have not examined a potential age effect in the general population specifically for paranoia. Further, whether paranoia's hierarchical nature (i.e. persecution representing a more severe dimension compared to social reference) may be differently impacted by a potential age effect has not been previously examined. Finally, no previous studies have attempted to identify the mechanisms involved in the decrease of paranoia with age. The aim of the present study was twofold: to explore the age effect on the hierarchical structure of paranoia and to explore whether the age effect is mediated by emotion regulation strategies such as rumination and thought suppression. Methods: A large sample of 1644 participants issued from the general population was recruited online. Participants were asked to complete questionnaires assessing paranoia and emotion regulation strategies (rumination and thought suppression). The sample was divided into three age groups (18-29; 30-54; 55-82 years old) and the effect of age on paranoia was examined using one-way ANOVAs. Mediational analyses were performed in order to explore whether emotion regulation strategies mediate the relationship between age and paranoia. Results: Results showed a significant decrease of social reference with age but not of persecution. Specifically, the youngest group scored higher on social reference than both the middle and the older age group. No significant difference was found between the middle and the older age group. These results indicate that young adults experience more social reference thoughts than mature adults. Finally, mediational analyses demonstrated that the negative relation between age and social reference was partially mediated by rumination and thought suppression. Discussion: For the first time in the literature, the present study demonstrated that the different steps of the hierarchy of paranoia are not equally affected by age. In particular, a decrease of social reference thought was observed with age but not for persecution. In addition, the results emphasize the role of emotion regulation strategies such as rumination and thought suppression as psychological mechanisms underpinning the decrease of paranoia with age. Such results confirm that emotion regulation strategies are important factors to take into account when trying to understand the nature of paranoia.
S59. A CLUSTER-ANALYTIC APPROACH
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Background: Motivation deficits have been linked to poor functional outcomes in schizophrenia (SZ) and major depressive disorder (MDD) and represent an unmet therapeutic need. Recent conceptualizations of the motivation system have outlined five inter-related reward processes, whereby (1) reward responsiveness (i.e. "liking") and (2) reward prediction (i.e. "wanting", established through appropriate reward learning) converge to inform both (3) reward valuation and (4) effort valuation which is associated with a cost-benefit analysis, followed by (5) the development and execution of an action plan to achieve the desired outcome. The inclusion of approach motivation within the RDoC Positive Valence System further underscores its importance as a pervasive symptom that cuts across traditional diagnostic boundaries. Previous investigations, however, have typically only focused on isolated reward processes, often within single diagnostic groups. Thus, in line with emerging dimensional approaches to examining psychopathology, the present study sought to utilize a cluster-analytic approach to objectively evaluate the multiple facets of the motivation system concurrently across SZ, MDD, and healthy control (HC) participants. Methods: The study sample consisted of 39 SZ, 38 MDD, and 39 HC participants. Participants were administered a series of assessments to evaluate symptom severity and cognitive functioning. Discrete facets of the motivation system were measured using an extensive battery of objective computerized tasks. Variables of interest were extracted from each task and entered into a principal components analysis in order to explore the factor structure of the motivation framework. Factor scores were subsequently applied to K-means cluster analysis to identify subgroups of individuals with similar motivation profiles. Results: Principal components analysis revealed five distinct motivation factors: hedonic capacity, reward expectancy and learning, cost-benefit decisionmaking, goal-directed decision-making, and effort expenditure. K-means clustering identified two distinct subgroups of individuals based on their motivation task performance. The first cluster demonstrated impaired hedonic capacity (t(114)=-3.7, p<.001), whereas the second cluster was characterized by impairments in cost-benefit decision-making (t(114)=5.9, p<.001), goal-directed decision-making (t(114)=7.3, p<.001), and effort expenditure (t(114)=6.3, p<.001). Although clusters did not differ in symptom severity, the second cluster was associated with significantly greater cognitive impairments (t(114)=6.4, p<.001). Importantly, all diagnostic groups were well represented in each cluster, though with significantly different distributions. Discussion: Our dimensional investigation revealed a multi-faceted motivation framework comprised of five distinct components. The emergence of two unique motivation performance profiles highlights the extensive heterogeneity of clinical amotivation and its dimensionality across disorders. Further, the pattern of motivation impairments within these profiles raises the possibility of distinct underlying neural substrates, with implications for specific therapeutic targets. Background: Evidence suggests that positive psychotic symptoms are more prevalent in early adulthood. However, studies have not examined a potential age effect in the general population specifically for paranoia. Further, whether paranoia's hierarchical nature (i.e. persecution representing a more severe dimension compared to social reference) may be differently impacted by a potential age effect has not been previously examined. Finally, no previous studies have attempted to identify the mechanisms involved in the decrease of paranoia with age. The aim of the present study was twofold: to explore the age effect on the hierarchical structure of paranoia and to explore whether the age effect is mediated by emotion regulation strategies such as rumination and thought suppression. Methods: A large sample of 1644 participants issued from the general population was recruited online. Participants were asked to complete questionnaires assessing paranoia and emotion regulation strategies (rumination and thought suppression). The sample was divided into three age groups (18-29; 30-54; 55-82 years old) and the effect of age on paranoia was examined using one-way ANOVAs. Mediational analyses were performed in order to explore whether emotion regulation strategies mediate the relationship between age and paranoia. Results: Results showed a significant decrease of social reference with age but not of persecution. Specifically, the youngest group scored higher on social reference than both the middle and the older age group. No significant difference was found between the middle and the older age group. These results indicate that young adults experience more social reference thoughts than mature adults. Finally, mediational analyses demonstrated that the negative relation between age and social reference was partially mediated by rumination and thought suppression. Discussion: For the first time in the literature, the present study demonstrated that the different steps of the hierarchy of paranoia are not equally affected by age. In particular, a decrease of social reference thought was observed with age but not for persecution. In addition, the results emphasize the role of emotion regulation strategies such as rumination and thought suppression as psychological mechanisms underpinning the decrease of paranoia with age. Such results confirm that emotion regulation strategies are important factors to take into account when trying to understand the nature of paranoia. Background: Clinical high risk (CHR) for psychosis is a heterogeneous syndrome presenting with highly variable clinical symptoms and cognitive dysfunctions. This study investigated whether subtypes defined by clinical and cognitive features in the initial presentation in CHR might improve the prediction of psychosis. Methods: From the ongoing ShangHai at Risk for Psychosis (SHARP) program, a total of 400 CHR subjects were enrolled in a prospective cohort study. Canonical correlation analysis (CCA) was applied to 289 CHR subjects with completed structured interviews for prodromal symptoms and MATRICS consensus cognitive battery tests at baseline, and at least 1-year follow-up. Canonical variates were generated by CCA and then used for hierarchical cluster analysis to produce subtypes. To test further the utility of 3 subtypes in predicting psychosis, Kaplan-Meyer survival curves were constructed from the 3 subtypes. Results: CCA determined two linear combinations: 1) Negative symptom and functional deterioration-related cognitive features; and 2) Positive symptoms and emotional disorganization-related cognitive features. Cluster analysis revealed 3 subtypes defined by distinct and relatively homogeneous patterns along two dimensions, and comprising 14.2% (subtype-1, n=41), 37.4% (subtype-2, n=108), and 48.4% (subtype-3, n=140) of the sample, each with distinctive features of clinical and cognitive performance. Those with subtype-1, which is characterized by extensive negative symptoms and cognitive deficits, appear to have the highest risk for psychosis. The conversion risk for subtypes 1-3 are 39.0%, 11.1% and 18.6%, respectively. Discussion: Our results define important subtypes within CHR syndromes that highlight clinical symptoms and cognitive features that transcend current diagnostic boundaries. The three different subtypes were associated with significant differences in their clinical and cognitive characteristics as well as in their risk of conversion to psychosis. Background: A key challenge in the field of neuropsychiatry lies in matching patients to effective treatments. Most studies operate under the canonical assumption that categorical diagnostic groupings (such as schizophrenia and bipolar disorder) and/or pre-existing clinical assessments (such as the PANSS) are the 'gold standard' for describing behavioral and therefore neural variation in patients. Attempts to robustly characterize the neural substrates of these symptom measures have yielded limited success, suggesting an inadequate mapping to neurobiologically meaningful variation. Notably, a great deal of behavioral and neural heterogeneity exists even within groups of patients with the same diagnosis. Thus, understanding the mapping between specific symptoms and clinically meaningful variation in neural properties is critical to developing, and ultimately administering, effective individualized treatment.
S60. AGE EFFECT ON THE HIERARCHICAL
S61. CLINICAL SUBTYPES THAT PREDICT
S62. NEURO-BEHAVIORAL RELATIONSHIPS IN DIMENSIONAL GEOMETRIC EMBEDDING: UNIFYING CATEGORIES AND DIMENSIONS ALONG THE PSYCHOSIS SPECTRUM
Methods:
Here, we describe a multivariate neurobehavioral framework under which behavioral variation in psychosis spectrum disorders can be mapped to features of specific neural systems in a data-driven way. We leverage neural (fMRI-derived) and behavioral data from 202 healthy controls and 436 patients from the Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes study. The patient sample includes 167 individuals with a formal diagnosis of schizophrenia, 119 with a diagnosis of schizoaffective disorder, and 150 with bipolar disorder with psychosis. We first identify dimensions of behavioral variation in patients by performing a principal component analysis across all behavioral measures. Next, using data-driven multivariate techniques including canonical correlation analysis, we show that variation along these behavioral dimensions relates to variation in the global brain connectivity of specific neural systems in the cortex and subcortex. Throughout our analyses, we use permutation testing to nonparametrically assess for significance, and explicitly test for site effects and robustness using both leave-one-site-out and k-fold crossvalidation. Finally, we demonstrate that these brain-behavioral relationships along the psychosis spectrum can be readily mapped to neural/cellular properties such as gene expression. Results: Importantly, the behavioral dimensions of maximal variation identified via PCA are not parallel to traditional symptom scales from preexisting clinical instruments, and do not reflect conventional diagnostic boundaries. These behavioral axes are highly stable and robust to site and sample effects. Further, we observe robust neurobehavioral relationships using our data-driven behavioral dimensions that are not present using either traditional diagnostic groups or a priori clinical scales. We further show that this framework can inform the identification of pharmacological targets aimed at treating specific symptom profiles and may assist in selecting behavioral measures that precisely pinpoint neural variation at the individual level. Discussion: Characterizing how and which specific sets of symptoms map to neural circuitry is a key step towards developing targeted and effective treatments for schizophrenia and psychosis spectrum disorders. Using such a framework, we can identify genetic and molecular targets that are associated with specific dimensions of behavioral variation and develop pharmaceutical agents that may address deficits along these axes. We propose the Neuro-Behavioral Relationships In Dimensional Geometric Embedding (N-BRIDGE) framework as a key step towards unified mapping between the geometry of behavioral variation and the geometry of neural variation in psychiatry. 
S63. SYNDROMAL AND UNDIFFERENTIATED
University of Pretoria
Background: Existing literature on anxiety in schizophrenia is confined to well-established diagnostic syndromes as defined independently from and outside the context of schizophrenia. It is not known yet whether anxiety that is not differentiated into these syndromes (that is, undifferentiated anxiety) is empirically discernible from syndromal anxiety in acute phase schizophrenia and whether it amounts to an entity discernible from no anxiety.
Methods:
The study compared anxiety features among 111 participants in an acute phase of schizophrenia, stratified into three groups after sampling. One group met DSM-IV diagnostic criteria for one or more of the syndromal anxiety disorders irrespective of having undifferentiated anxiety features concurrently. The second group did not meet DSM-IV diagnostic criteria for anyone of the syndromal anxiety disorders yet qualified for the DSM-IV diagnosis of anxiety disorder not otherwise specified. The third group comprised patients who did not meet DSM-IV diagnostic criteria for any syndromal anxiety disorder, nor for an anxiety disorder not otherwise specified. The groups were stratified by using the SCID either directly
